Aglaia Oncology Funds
Bilthoven, Netherlands · Pre-seed → Seed
Their stated focus (public profile)
Aglaia Oncology Funds invests in early-stage oncology drug development companies, focusing on breakthrough inventions with the potential to transform cancer treatment. Since 2004, Aglaia has built and co-founded biotech companies, providing hands-on strategic and operational involvement from early screening through clinical studies. The fund aims to de-risk and mature portfolio companies until they become attractive candidates for licensing, acquisition, or IPO.
Stages: Pre-seed → Seed
Sectors: Healthtech, Life sciences
On file: 5 partners on record
Website: aglaia-oncology.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.